Skip to content
FIND A HEALTH VALLEY ACTOR

Ecotope, the new EPFL Innovation Park’s project

Ecotope 1

EPFL Innovation Park is turning 30 this year and wants to expand. A new site, called Ecotope,  will bring together startups, researchers and outside companies. The Canton of Vaud is the project’s main partner.   The EPFL Innovation Park is already home to over 150 startups and 30 large companies employing over 2,600 people. In…

Read More

A CHF 12 Million Innosuisse Grant for a VR Surgical Training Method

ORama VR

The Swiss Federal Agency for Innovation Promotion (Innosuisse) is supporting the “PROFICIENCY” project, in which the Geneva-based startup ORamaVR S.A. is a full partner, with a total of CHF 12 million over the next four years.   The project initiates a paradigm shift in practical training in surgery: Away from primary training in the operating…

Read More

CSEM Digital Journey : win CHF 100,000 worth of technical support

CSEM Digital Journey 2026

Apply before 14 September 2026 for CSEM Digital Journey competition. The innovation center will support a company trying to realize its digital project with technological support worth CHF 100,000.    The “Digital Journey”started in 2018 and provides companies with fewer than 250 employees an opportunity to access CSEM‘s technological expertise to implement an important digitalization…

Read More

AlveoliX wins the Swiss Medtech Award 2022

AlveoliX Swiss Medtech Award

Bernese start-up AlveoliX was awarded the Swiss Medtech Award, and prize money totaling CHF 75,000.   AlveoliX, founded in 2019, has created a small-scale replica of the human lung called «Lung-on-Chip» that can also mimic respiratory motions. According to the jury, this organ-on-chip technology has the potential to establish itself as the new standard in…

Read More

CHUV strengthens its strategy to fight cancer

Solange Peters Chuv

The University Hospital of Vaud (CHUV) in Lausanne is expanding its strategy to better fight all forms of cancer. The institution is opening three new interdisciplinary oncology centers, focusing on the brain and spinal cord, liver and pancreas, and ENT and cervicofacial tumors.   The University Hospital of Vau, CHUV, had already been a pioneer…

Read More

BioAlps at OM Pharma

BioAlps OM Pharma 4à6

On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma in Geneva.   OM Pharma is a leader in the prevention of recurrent respiratory and urinary tract infections with products regulating the immune system based on oral bacterial extracts. Broncho-Vaxom® and Uro Vaxom® are marketed…

Read More

Cytiva opens a new production site in Grens (VD)

Cityva 3D

Cytiva opens its new 7,400 m2 production facility in Grens, Switzerland, on 31 May 2022.   The site will manufacture single-use kits for the Sepax and Sefia cell processing systems, as well as consumables for the Xuri cell expansion systems. The new site will be home to 250 employees and house the Centre of Excellence…

Read More

Votes are open for the TOP 100 Swiss Startups! 

Top Swiss Startups

What is your favorite swiss startup?   Every year the TOP 100 Swiss Startup Award showcases the 100 most innovative and promising Swiss startups. 438 Swiss deeptech startups have been featured in the ranking over the past decade. So far, they have created 11100 jobs and raised CHF 6.1 billion. In 2022, 269 Life Sciences…

Read More

Pr. Antoine Geissbuhler is the new BioAlps’ President

Prof. Antoine Geissbuhler BioAlps President

A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster in Europe   After a selection process of several months, BioAlps’ Executive Committee identified a strong candidate to take over the role of Mr Claude Clément as President of the BioAlps Association. On Thursday 19…

Read More

Alithea Genomics closes a CHF 1 million seed round

Alithea Genomics

Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with the participation of Swiss-based private investors.   Alithea has developed a proprietary technology called Bulk RNA Barcoding and sequencing (BRB-seq), which enables the preparation…

Read More